Aviva Gross

1.2k total citations
15 papers, 845 citations indexed

About

Aviva Gross is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Neurology. According to data from OpenAlex, Aviva Gross has authored 15 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Pharmacology and 5 papers in Neurology. Recurrent topics in Aviva Gross's work include Cholinesterase and Neurodegenerative Diseases (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Aviva Gross is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Aviva Gross collaborates with scholars based in Israel, Germany and United States. Aviva Gross's co-authors include Moussa B. H. Youdim, J. P. M. Finberg, Michael Gassen, Marta Weinstock, Tatyana Poltyrev, Elena Gorodetsky, M.B.H. Youdim, Corina Bejar, Yotam Sagi and Orly Weinreb and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Aviva Gross

15 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aviva Gross Israel	12	367	283	264	169	152	15	845
Yotam Sagi United States	18	238 0.6×	418 1.5×	235 0.9×	284 1.7×	197 1.3×	23	876
M Naoi Japan	8	270 0.7×	207 0.7×	139 0.5×	150 0.9×	103 0.7×	11	544
Masayo Shamoto‐Nagai Japan	23	579 1.6×	448 1.6×	228 0.9×	634 3.8×	375 2.5×	32	1.6k
Michael Gassen Israel	15	433 1.2×	370 1.3×	87 0.3×	280 1.7×	140 0.9×	18	950
Andres D. Ramirez United States	13	96 0.3×	219 0.8×	277 1.0×	332 2.0×	74 0.5×	16	798
Tjerk Bueters Sweden	17	93 0.3×	270 1.0×	157 0.6×	284 1.7×	201 1.3×	40	1.0k
Gianni Benzi Italy	10	95 0.3×	146 0.5×	181 0.7×	330 2.0×	280 1.8×	21	884
Timothy T. Soncrant United States	25	123 0.3×	525 1.9×	408 1.5×	436 2.6×	228 1.5×	52	1.5k
Corina Bejar Israel	17	71 0.2×	241 0.9×	400 1.5×	216 1.3×	308 2.0×	21	1.1k
Tianfang Jiang China	9	351 1.0×	166 0.6×	138 0.5×	305 1.8×	302 2.0×	15	1.0k

Countries citing papers authored by Aviva Gross

Since Specialization

Citations

This map shows the geographic impact of Aviva Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviva Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviva Gross more than expected).

Fields of papers citing papers by Aviva Gross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviva Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviva Gross. The network helps show where Aviva Gross may publish in the future.

Co-authorship network of co-authors of Aviva Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Aviva Gross. A scholar is included among the top collaborators of Aviva Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviva Gross. Aviva Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Shinar, Doron, et al.. (2018). TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene. Drug and Alcohol Dependence. 188. 295–303. 15 indexed citations

Rabinovich‐Guilatt, Laura, et al.. (2018). Pharmacokinetics and safety of single and multiple doses of rasagiline in healthy Japanese and caucasian subjects. Basic & Clinical Pharmacology & Toxicology. 124(3). 273–284. 9 indexed citations

Cohen‐Barak, Orit, Aviva Gross, Merav Bassan, et al.. (2014). Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects. The Journal of Clinical Pharmacology. 55(5). 573–583. 48 indexed citations

Bar‐Am, Orit, Aviva Gross, Rachel S. Friedman, & J. P. M. Finberg. (2012). Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase. European Journal of Pharmacology. 683(1-3). 226–230. 5 indexed citations

Finberg, J. P. M., et al.. (2006). Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L‐DOPA in the rat. British Journal of Pharmacology. 149(6). 647–656. 13 indexed citations

Ron, Benny, et al.. (2006). A possible new role for fish retinal serotonin-N-acetyltransferase-1 (AANAT1): Dopamine metabolism. Brain Research. 1073-1074. 220–228. 31 indexed citations

Moses, David, Aviva Gross, & J. P. M. Finberg. (2004). Rasagiline enhances l-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig. Neuropharmacology. 47(1). 72–80. 10 indexed citations

Weinstock, Marta, Elena Gorodetsky, Tatyana Poltyrev, et al.. (2003). A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(4). 555–561. 65 indexed citations

Weinstock, Marta, et al.. (2002). Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits11Supported by Teva Pharmaceuticals Ltd (Israel).. Neuropharmacology. 43(6). 999–1005. 33 indexed citations

10.

Youdim, Moussa B. H., Aviva Gross, & J. P. M. Finberg. (2001). Rasagiline [N‐propargyl‐1R(+)‐aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. British Journal of Pharmacology. 132(2). 500–506. 306 indexed citations

11.

Youdim, Moussa B. H., Michael Gassen, Aviva Gross, Silvia Mandel, & Edna Grünblatt. (2000). Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine. PubMed. 83–96. 29 indexed citations

12.

Weinstock, Marta, Corina Bejar, Tatyana Poltyrev, et al.. (2000). TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer’s disease. PubMed. 157–169. 103 indexed citations

13.

Gassen, Michael, Aviva Gross, & Youdim Mb. (1999). Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties.. PubMed. 80. 297–302. 19 indexed citations

14.

Gassen, Michael, Aviva Gross, & Moussa B. H. Youdim. (1998). Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H₂O₂ and 6‐hydroxydopamine. Movement Disorders. 13(2). 242–248. 119 indexed citations

15.

Gassen, Michael, Aviva Gross, & Moussa B. H. Youdim. (1998). Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H₂O₂ and 6‐Hydroxydopamine. Movement Disorders. 13(4). 661–667. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact